EGFR and neoplasm: However, if the tumor contains many branched events, indicating heterogeneity within the tumor, then even targeting the causative event may not have a significant effect on treatment outcome due to the low-frequency subpopulation carrying the branch resistance event, leading to subclonal selection and the acquisition of drug resistance, as observed with the mutation in EGFR in NSCLC [109].